Q3028 HCPCS code: Injection, interferon beta-1a, 1 mcg for subcutaneous use
Q3028 is the HCPCS Level II code for injection, interferon beta-1a, 1 mcg for subcutaneous use. Its Medicare coverage code is I (Not payable by Medicare): Medicare does not pay separately under this code; another code applies.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | I — Not payable by Medicare |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | O1E — Other drugs |
| Added | 2014-01-01 |
| Last action effective | 2014-01-01 |
What changed for Q3028
- 2014-01-01: Q3028 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q3028?
Q3028 is the HCPCS Level II code for injection, interferon beta-1a, 1 mcg for subcutaneous use. Short descriptor: "Inj beta interferon sq 1 mcg".
Does Medicare cover Q3028?
Coverage code I — Not payable by Medicare. Medicare does not pay separately under this code; another code applies.
Related Q30 codes
- Q3001 — Radioelements for brachytherapy, any type, each
- Q3014 — Telehealth originating site facility fee
- Q3027 — Injection, interferon beta-1a, 1 mcg for intramuscular use
- Q3031 — Collagen skin test
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q3028
- Watch Q3028 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q3028
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.